Article
The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.
Clinical pharmacology and therapeutics - 1 Dec 2006
Skarke Carsten, Reus Maximilian, Schmidt Ronald, Grundei Inga, Schuss Patrick, Geisslinger Gerd, Lötsch Jörn
Abstract excerpt
OBJECTIVE: Our objective was to assess the role of the reportedly functional PTGS2 (prostaglandin-endoperoxide synthase 2/cyclooxygenase [COX] 2) promoter mutation -765G>C for the COX-2-inhibiting effects of celecoxib. METHODS: Twenty healthy carriers of the -765GG genotype and -765CC genotype (n = 10 each) received 200 mg of celecoxib orally. Blood samples were drawn at baseline and at 1, 3, 6, 9, and 24 hours...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
